Europe Allergy Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Allergy Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Allergy Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Allergy Treatment Market Regional Analysis

6.2 Europe Allergy Treatment Market Revenue 2018-2028 (US$ Million)

6.3 Europe Allergy Treatment Market Forecast Analysis

7. Europe Allergy Treatment Market Analysis – by Allergy Type

7.1 Eye Allergy

7.1.1 Overview
7.1.2 Eye Allergy: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.2 Rhinitis

7.2.1 Overview
7.2.2 Rhinitis: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.3 Asthma

7.3.1 Overview
7.3.2 Asthma: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.4 Skin Allergy

7.4.1 Overview
7.4.2 Skin Allergy: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.5 Food Allergies

7.5.1 Overview
7.5.2 Food Allergies: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

7.6 Other Allergies

7.6.1 Overview
7.6.2 Other Allergies: Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

8. Europe Allergy Treatment Market Analysis – by Treatment

8.1 Anti-Allergy Drugs and Immunotherapy

8.1.1 Overview
8.1.2 Anti-Allergy Drugs and Immunotherapy : Europe Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)

9. Europe Allergy Treatment Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Allergy Treatment Market Breakdown, by Key Country, 2021 and 2028 (%)
9.2.1.1 Europe Allergy Treatment Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 UK: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.1.2 UK: Europe Allergy Treatment Market Breakdown, by Treatment

9.2.1.2 Germany: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Germany: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.2.2 Germany: Europe Allergy Treatment Market Breakdown, by Treatment

9.2.1.3 France: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 France: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.3.2 France: Europe Allergy Treatment Market Breakdown, by Treatment

9.2.1.4 Russia: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.4.1 Russia: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.4.2 Russia: Europe Allergy Treatment Market Breakdown, by Treatment

9.2.1.5 Italy: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.5.1 Italy: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.5.2 Italy: Europe Allergy Treatment Market Breakdown, by Treatment

9.2.1.6 Rest of Europe: Europe Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Allergy Treatment Market Breakdown, by Allergy Type
9.2.1.6.2 Rest of Europe: Europe Allergy Treatment Market Breakdown, by Treatment

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 LETI Pharma

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Dermapharm Holding Se

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Johnson and Johnson Services, Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Sanofi

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 AbbVie's Inc.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Pfizer

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 ALK-Abelló A/S

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Allergy Therapeutics

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Stallergenes Greer

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 GlaxoSmithKline PLC

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Allergy Treatment Market

Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies) and Treatment (Anti-Allergy Drugs and Immunotherapy)